We recently compiled a list of the 12 Best ADR Stocks to Buy According to Hedge Funds. In this article, we are going to take ...

GSK (LON:GSK – Get Free Report)‘s stock had its “underweight” rating reaffirmed by equities research analysts at JPMorgan ...

Stock analysts at Zacks Research upped their FY2027 earnings per share estimates for GSK in a report issued on Tuesday, March ...

GSK PLC closed 18.56% short of its 52-week high of £18.24, which the company achieved on May 16th.

could cause cancer were “admissible”, sparking a sell-off in GSK shares that wiped billions off its market cap. Now, the drugmaker and co-defendants, including Pfizer, Sanofi, and Boehringer ...

In this article, we are going to take a look at where GSK plc (NYSE:GSK ... Research has increased its prediction for the global market for obesity medications from $77 billion to $105 billion ...

GSK (NYSE:GSK) shares rose for seven straight sessions, as the stock ended 0.7% higher at $40.32 on Monday. The pharmaceutical giant gained over 6.5% in the preceding six sessions. The stock has ...

In a report released today, Emily Field from Barclays maintained a Hold rating on GlaxoSmithKline (GSK – Research Report), with a price target of £14.50. The company’s shares opened today at ...

Shares of GSK PLC GSK slipped 1.73% to £15.05 Wednesday, on what proved to be an all-around positive trading session for the ...